Pharmacy

October 23, 2025 | Opioids, Pharmacy, Reports & Studies, Substance Use Disorder, Treatments

In collaboration with the University of Rhode Island College of Pharmacy, the Legislative Analysis and Public Policy Association (LAPPA) recently released "Pharmacists and Buprenorphine: Analysis of State Laws and Regulations." Funded by the Foundation for Opioid Response Efforts (FORE) Foundation, this project, named Pharmacy Bridge, focused on a demonstration of the real-world application and outcomes of two innovative models of pharmacy-based, low-barrier buprenorphine induction and maintenance services: (1) collaborative care through a collaborative practice agreement (CPA); and (2) independent pharmacist prescribing of buprenorphine. The report contains state-by-state descriptions and analyses of relevant statutes and regulations as well as a detailed summary of overall findings....

August 11, 2025 | Controlled Substances, Harm Reduction, Legal & Legislative Research, Opioids, Pharmacy, Prescription Drugs, Public Health, Public Safety, Substance Misuse

In this document, the Legislative Analysis and Public Policy Association examines state-level legislative and administrative responses to the public health risk posed by expired and unused prescription medications. In the last several years, states, in coordination with the Federal Drug Enforcement Administration (DEA) have enacted legislation or promulgated administrative regulations to authorize drug take-back programs where expired or unused pharmaceuticals can be collected from the public by authorized persons and disposed of in a safe manner. Findings are presented by state for ease of comparison....

May 22, 2024 | Medication Assisted Treatment (MAT), Model Laws, Pharmacy, Recovery, Treatments

The Model Pharmacist Collaboration for Medication for Opioid Use Disorder Act, drafted in collaboration with the Center for Health Law Studies at the St. Louis University School of Law, can help to save the lives and improve the health and quality of life of individuals who have an opioid use disorder (OUD) by expanding access to and availability of medication for OUD....